Skip to content

Nu Skin Conductive Gel 1003913Recalls & reported problems

Nse Products, Inc. · Class 2

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00860196000310), received between Mar 18, 2021 and Jun 16, 2025 — classified as 2 injuries.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 1 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem2

Patient problems

  • Convulsion/Seizure1
  • Headache1
  • Malaise1
  • Skin Disorders1
  • Unspecified Tissue Injury1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • InjuryJun 16, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    ON (B)(6) 2025, A SPONTANEOUS REPORT WAS RECEIVED VIA TELEPHONE REGARDING A FEMALE (AGE NOT PROVIDED) WHO USED NU SKIN FACIAL SPA (REFER TO ASSOCIATED REPORT) AND NU SKIN CONDUCTIVE GEL. ON AN UNSPECIFIED DATE IN (B)(6) 2024, THE CONSUMER STARTED USING THE PRODUCTS. APPROXIMATELY 3 WEEKS AFTER USING THE PRODUCTS, SHE STARTED TO NOTICE ONE OF HER EYELIDS WAS DROOPING OR SAGGING. SHE DID NOT NOTICE ANY BENEFIT FROM THE PRODUCTS. HER HUSBAND COULDN'T TELL ANY DIFFERENCE BUT WHEN SHE LOOKED AT OLD PICTURES SHE COULD. SHE THOUGHT HER ENTIRE FOREHEAD WAS SAGGING DOWNWARD. OVER TIME SHE NOTICED HER EYELIDS AND EYEBROWS WERE SAGGING TO WHERE IT AFFECTED HER VISION AND SHE HAD A DAILY HEADACHE. SHE DISCONTINUED THE PRODUCT IN (B)(6) 2025. ON AN UNSPECIFIED DATE SHE VISITED HER PRIMARY CARE PROVIDER WHO RECOMMENDED SHE SEE AN EYE DOCTOR. WHEN SHE VISITED AN EYE DOCTOR A VISION TEST WAS DONE WHICH SHE REPORTED 47% OF HER VISION WAS AFFECTED BY THE SAGGING SKIN. SHE THEN MADE AN APPOINTMENT WITH AN EYE SURGEON WHO MEASURED THE DISTANCE FROM HER PUPILS TO HER EYELIDS. SHE ANTICIPATED HAVING SURGERY ON (B)(6) 2025. AT THE TIME OF THE REPORT THE SYMPTOMS WERE ONGOING.

    Patient problems: Headache; Skin Disorders

    MAUDE report 22212944 ↗
  • InjuryMar 18, 2021Adverse Event Without Identified Device or Use Problem

    THIS SPONTANEOUS REPORT WAS RECEIVED FROM A CONSUMER REGARDING A (B)(6) -YEAR-OLD MALE PATIENT ON (B)(6) 2021. REPORTER STATES THAT HER BOYFRIEND, THE (B)(6) -YEAR-OLD MALE PATIENT, USED THE FACIAL SPA PRODUCT (BOTH NU SKIN FACIAL SPA AND NU SKIN CONDUCTIVE GEL), ON (B)(6) 2021. ON (B)(6) 2021 AT APPROXIMATELY 0230 THE PATIENT HAD A SEIZURE, UNSPECIFIED TYPE, AND BIT HIS TONGUE WHICH RESULTED IN BLEEDING. THE PATIENT DID NOT HAVE A PREVIOUS HISTORY OF SEIZURES. AFTER THE SEIZURE ACTIVITY DEVELOPED THE REPORTER CALLED EMERGENCY MEDICAL SERVICES (EMS) AND THE PATIENT WAS TRANSPORTED TO THE EMERGENCY DEPARTMENT (ED). AT THE ED THE PATIENT HAD A COMPUTERIZED TOMOGRAPHY SCAN (CT) AND MAGNETIC RESONANCE IMAGING (MRI). BOTH THE CT AND MRI WERE NORMAL. THE TREATING PRACTITIONER WAS UNSURE WHAT CAUSED THE SEIZURE ACTIVITY. THE PATIENT WAS MONITORED AND OBSERVED IN THE ED FOR SEVERAL HOURS BUT WAS NOT ADMITTED TO THE HOSPITAL. HE WAS PRESCRIBED UNSPECIFIED ANTICONVULSANT MEDICATION(S). AT THE TIME OF THE CALL ON (B)(6) 2021 THE REPORTER COMMENTED THAT THE PATIENT WAS IMPROVING BUT WAS STILL WEAK. AN EEG IS SCHEDULED FOR THE WEEK OF (B)(6) 2021. (B)(6) 2021: FOLLOW-UP CALL MADE TO THE REPORTE

    Patient problems: Convulsion/Seizure; Malaise; Unspecified Tissue Injury

    MAUDE report 11516227 ↗

Other MEDIA, ELECTROCONDUCTIVE devices

All MEDIA, ELECTROCONDUCTIVE devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page